References
- Rao GG, Batura D, Batura N, et al. Key demographic characteristics of patients with bacteriuria due to extended spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae in a multiethnic community in North West London. Infect Dis. 2015;47:719–724.
- Abreu AG, Marques SG, Monteiro Neto V, et al. Extended-spectrum beta-lactamase-producing Enterobacteriaceae in community-acquired urinary tract infections in São Luis, Brazil. Braz J Microbiol. 2013;44:469–471.
- Mawatari M, Hayakawa K, Fujiya Y, et al. Bacteraemic urinary tract infections in a tertiary hospital in Japan: the epidemiology of community-acquired infections and the role of non-carbapenem therapy. BMC Res Notes. 2017;10:336.
- Wollheim C, Guerra IMF, Conte VD, et al. Nosocomial and community infections due to class A extended-spectrum β-lactamase (ESBLA)-producing Escherichia coli and Klebsiella spp. in Southern Brazil. Brazilian J Infect Dis. 2011;15:138–143.
- Foxman B. The Epidemiology of urinary tract infection. Nat Rev Urol. 2010;7:653–660.
- Hussain Gilani SY, Ali Shah SR, Ahmad N, et al. Antimicrobial resistance patterns in community acquired urinary tract infections. J Ayub Med Coll Abbottabad. 2016;28:572–574.
- Ferdosi-Shahandashti E, Javanian M, Moradian-Kouchaksaraei B, et al. Resistance patterns of Escherichia coli causing urinary tract infection. Caspian J Intern Med. 2015;6:148–151.
- Chopra T, Marchaim D, Veltman J, et al. Impact of cefepime therapy on mortality among patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli. Antimicrob Agents Chemother. 2012;56:3936–3942.
- Braoios A, Turatti TF, Meredija LCS, et al. Urinary tract infections in non-hospitalized patients: etiology and antibiotic resistance patterns. J Bras Patol e Med Lab. 2009;45:449–456.
- Anvari MS, Naderan M, Boroumand MA, et al. Microbiologic spectrum and antibiotic susceptibility pattern among patients with urinary and respiratory tract infection. Int J Microbiol. 2014;2014:1-6.